Interleukin-10 (IL-10), IL-1β, mitogen-activated protein kinase (MAPK), IL-6, matrix metalloproteinase-3 (MMP-3), TNF-α and other targets have been confirmed to play important roles in the treatment of arthritis by CC. This evidence concerns the gene IL1B and arthritic joint disease.